+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Gene Transfer Technologies Market

  • PDF Icon

    Report

  • 81 Pages
  • September 2026
  • Region: Global
  • BCC Research
  • ID: 6290777
Description Jump to:
This brief report offers an overview of the global gene transfer technologies market and examines market trends. It includes worldwide revenue (in millions of dollars) for the base year 2025 and forecast data from 2026 to 2031. The market is segmented by delivery methods/mode into viral vectors, non-viral vectors, and physical techniques. Physical methods are sub-segmented into electroporation, gene guns, and microinjection. Based on application, the market segments include gene therapy, cell therapy, vaccines, and research. The regions analyzed in this study are North America, Europe, Asia-Pacific, and the Rest of the World.

The report focuses on key trends, challenges, and technological advances shaping the market and vendor landscape. The report concludes with an analysis of the competitive landscape of prominent companies in the global gene transfer technologies market. It also has a dedicated section of company profiles that covers details such as overview, product portfolio, and strategic developments of key companies in the market.

The report includes:

  • An overview and analysis of the global market for gene transfer technologies
  • Analyses of global market trends, with revenue data for 2025, estimates for 2026, and projections of CAGRs through 2031 (in $ Millions)
  • Estimates of the current market size and revenue growth prospects for the global market, along with a market share analysis by mode, application and region
  • Facts and figures related to market dynamics, including drivers, restraints and opportunities influencing the market
  • Discussion of emerging technologies and developments in gene transfer technologies
  • Competitive intelligence, including strategic analysis of key companies operating in the market
  • Profiles of leading companies in the global gene transfer technologies market

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
  • Market Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion
Chapter 2 Market Overview
  • Market Definition
  • Technology Background
  • Viral Vector Gene Delivery Systems
  • Non-viral Vector Gene Delivery Systems
  • Physical Methods
  • PESTEL Analysis
  • Impact of U.S. Tariff Laws on the Gene Transfer Technologies Market
  • Effects on Supply Chain
  • Opportunities for Local Production
  • Conclusion
Chapter 3 Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Growing Cell and Gene Therapy Market
  • Rising Prevalence of Chronic Diseases
  • Market Restraints
  • Lack of Skilled Workforce
  • Production Scalability Issues
  • Market Opportunities
  • Advances in Gene Editing Technologies
  • Increasing Collaborations and Partnerships
Chapter 4 Emerging Technologies and Developments
  • Overview
  • CRISPR/ Cas9 Genome Editing
  • Artificial Intelligence in Gene Transfer Technology
Chapter 5 Market Segmentation Analysis
  • Segmentation Breakdown
  • Market Breakdown by Mode
  • Key Takeaways
  • Viral Vectors
  • Non-viral Vectors
  • Physical Methods
  • Market Breakdown by Application
  • Key Takeaways
  • Gene Therapy
  • Research
  • Cell Therapy
  • Vaccines
  • Geographic Breakdown
  • Market Breakdown by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 6 Competitive Intelligence
  • Key Takeaways
  • Leading Companies in the Gene Transfer Technologies Market
  • Strategic Analysis
  • Key Strategies of Prominent Companies in the Gene Transfer Technologies Market
Chapter 7 Appendix
  • Methodology
  • Abbreviations
  • References
Company Profiles
  • 4D MOLECULAR THERAPEUTICS
  • BIO-RAD LABORATORIES INC.
  • CREATIVE BIOLABS
  • LONZA
  • MAXCYTE
  • MERCK KGAA
  • OXFORD BIOMEDICA PLC
  • QIAGEN
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table: Global Market for Gene Transfer Technologies, by Region, Through 2031
Table 1: Key Research Collaborations and Partnerships
Table 2: Global Market for Gene Transfer Technologies, by Mode, Through 2031
Table 3: Viral Vectors in Gene Therapy Products
Table 4: Approved Viral Vector-based Gene Therapy Products
Table 5: Global Market for Gene Transfer Technologies for Viral Vectors, by Region, Through 2031
Table 6: Global Market for Gene Transfer Technologies for Non-Viral Vectors, by Region, Through 2031
Table 7: Global Market for Gene Transfer Technologies for Physical Methods, by Region, Through 2031
Table 8: Global Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 9: Global Market for Gene Transfer Technologies for Electroporation, by Region, Through 2031
Table 10: Global Market for Gene Transfer Technologies for Microinjection, by Region, Through 2031
Table 11: Global Market for Gene Transfer Technologies for Gene Gun, by Region,Through 2031
Table 12: Global Market for Gene Transfer Technologies, by Application, Through 2031
Table 13: Global Market for Gene Transfer Technologies for Gene Therapy, by Region, Through 2031
Table 14: Global Market of Gene Transfer Technologies for Research, by Region, Through 2031
Table 15: Global Market of Gene Transfer Technologies for Cell Therapy, by Region, Through 2031
Table 16: Global Market of Gene Transfer Technologies for Vaccines, by Region, Through 2031
Table 17: Global Market for Gene Transfer Technologies, by Region, Through 2031
Table 18: North American Market for Gene Transfer Technologies, by Mode, Through 2031
Table 19: North American Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 20: North American Market for Gene Transfer Technologies, by Application, Through 2031
Table 21: European Market for Gene Transfer Technologies, by Mode, Through 2031
Table 22: European Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 23: European Market for Gene Transfer Technologies, by Application, Through 2031
Table 24: Asia-Pacific Market for Gene Transfer Technologies, by Mode, Through 2031
Table 25: Asia-Pacific Market of Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 26: Asia-Pacific Market for Gene Transfer Technologies, by Application, Through 2031
Table 27: RoW Market for Gene Transfer Technologies, by Mode, Through 2031
Table 28: RoW Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 29: RoW Market for Gene Transfer Technologies, by Application, Through 2031
Table 30: Vector Manufacturing Portfolio of Key Companies in the Gene Transfer Technologies Market
Table 31: Recent Developments: Gene Transfer Technologies Market, 2023-2026
Table 32: Abbreviations Used in this Report
Table 33: 4D Molecular Therapeutics: Company Snapshot
Table 34: 4D Molecular Therapeutics: Financial Performance, FY 2024 and 2025
Table 35: 4D Molecular Therapeutics: Product Portfolio
Table 36: 4D Molecular Therapeutics: News/Key Developments, 2023-2025
Table 37: Bio-Rad Laboratories Inc.: Company Snapshot
Table 38: Bio-Rad Laboratories Inc.: Financial Performance, FY 2024 and 2025
Table 39: Bio-Rad Laboratories Inc.: Product Portfolio
Table 40: Bio-Rad Laboratories Inc.: News/Key Developments, 2025
Table 41: Creative Biolabs: Company Snapshot
Table 42: Creative Biolabs: Product Portfolio
Table 43: Creative Biolabs: News/Key Developments, 2025-2026
Table 44: Lonza: Company Snapshot
Table 45: Lonza: Financial Performance, FY 2024 and 2025
Table 46: Lonza: Product Portfolio
Table 47: MaxCyte: Company Snapshot
Table 48: MaxCyte: Financial Performance, FY 2024 and 2025
Table 49: MaxCyte: Product Portfolio
Table 50: MaxCyte: News/Key Developments, 2025-2026
Table 51: Merck KGaA: Company Snapshot
Table 52: Merck KGaA: Financial Performance, FY 2024 and 2025
Table 53: Merck KGaA: Product Portfolio
Table 54: Merck KGaA: News/Key Developments, 2024
Table 55: Oxford Biomedica PLC: Company Snapshot
Table 56: Oxford Biomedica PLC: Financial Performance, FY 2024 and 2025
Table 57: Oxford Biomedica PLC: Product Portfolio
Table 58: Oxford Biomedica PLC: News/Key Developments, 2023-2026
Table 59: Qiagen: Company Snapshot
Table 60: Qiagen: Financial Performance, FY 2024 and 2025
Table 61: Qiagen: Product Portfolio
Table 62: Qiagen: News/Key Developments, 2025
Table 63: Sartorius AG: Company Snapshot
Table 64: Sartorius AG: Financial Performance, FY 2024 and 2025
Table 65: Sartorius AG: Product Portfolio
Table 66: Sartorius AG: News/Key Developments, 2023-2025
Table 67: Thermo Fisher Scientific Inc.: Company Snapshot
Table 68: Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
Table 69: Thermo Fisher Scientific Inc.: Product Portfolio
Table 70: Thermo Fisher Scientific Inc.: News/Key Developments, 2025
List of Figures
Summary Figure: Global Market Shares for Gene Transfer Technologies, by Region, 2025
Figure 1: PESTEL Analysis: Gene Transfer Technologies Market
Figure 2: Market Dynamics of Gene Transfer Technologies
Figure 3: Viral Vector-based Cell and Gene Therapy Clinical Trials
Figure 4: Investments in Cell and Gene Therapy, by Year
Figure 5: Global Market Shares for Gene Transfer Technologies, by Mode, 2025
Figure 6: Global Market Shares for Gene Transfer Technologies for Physical Methods, by Type, 2025
Figure 7: Global Market Shares for Gene Transfer Technologies, by Application, 2025
Figure 8: Global Market Shares for Gene Transfer Technologies, by Region, 2025
Figure 9: Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 10: Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 11: LONZA: Revenue Shares, by Business Unit, FY 2025
Figure 12: LONZA: Revenue Shares, by Region, FY 2025
Figure 13: MAXCYTE: Revenue Shares, by Business Unit, FY 2025
Figure 14: MAXCYTE: Revenue Shares, by Country/Region, FY 2025
Figure 15: Merck KGaA: Revenue Shares, by Business Unit, FY 2025
Figure 16: Merck KGaA: Revenue Shares, by Country/Region, FY 2025
Figure 17: Oxford Biomedica PLC: Revenue Shares, by Business Unit, FY 2025
Figure 18: Oxford Biomedica PLC: Revenue Shares, by Country/Region, FY 2025
Figure 19: QIAGEN: Revenue Shares, by Business Unit, FY 2025
Figure 20: QIAGEN: Revenue Shares, by Country/Region, FY 2025
Figure 21: Sartorius AG: Revenue Shares, by Business Unit, FY 2025
Figure 22: Sartorius AG: Revenue Shares, by Country/Region, FY 2025
Figure 23: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 24: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025

Executive Summary

This report provides an overview of the global gene transfer technologies market, analyzing key market trends, growth drivers, challenges, and emerging technologies. The market is segmented by vector type, application, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study also evaluates the impact of PESTEL factors, while offering strategic insights into the competitive landscape and profiles of leading companies. Market forecasts are provided through 2031.

Companies Mentioned

  • 4D MOLECULAR THERAPEUTICS
  • BIO-RAD LABORATORIES INC.
  • CREATIVE BIOLABS
  • LONZA
  • MAXCYTE
  • MERCK KGAA
  • OXFORD BIOMEDICA PLC
  • QIAGEN
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC INC.

Related Topics

Related Reports

Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029 - Product Image

Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029

  • Report
  • 525 Pages
  • Global
From
Viral Vector Manufacturing Markets and Technologies Through 2030 - Product Image

Viral Vector Manufacturing Markets and Technologies Through 2030

  • Report
  • 202 Pages
  • Global
From
Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036) - Product Image

Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

  • Report
  • 316 Pages
  • Global
From
Viral and Non-Viral Vector Manufacturing Market Report 2026 - Product Image

Viral and Non-Viral Vector Manufacturing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cell Transfection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Cell Transfection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.